Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof

Details for Australian Patent Application No. 2007334323 (hide)

Owner Amgen Inc.

Inventors Bryan, Marian C.; Biswas, Kaustav; Frohn, Michael J.; Tegley, Christopher M.; Reed, Anthony; Cao, Guo-Qiang; Allen, Jennifer R.; Golden, Jennifer E.; Mercede, Stephanie; Burli, Roland; Peterkin, Tanya; Neira, Susana; Wang, Xiang; Pickrell, Alexander J.

Agent Shelston IP

Pub. Number AU-B-2007334323

PCT Pub. Number WO2008/076427

Priority 60/963,152 01.08.07 US; 60/875,693 18.12.06 US

Filing date 17 December 2007

Wipo publication date 26 June 2008

Acceptance publication date 10 March 2011

International Classifications

C07D 311/96 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07C 59/88 (2006.01) Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O-metal, CHO, keto, ether, groups, groups, or groups

C07C 235/82 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 237/24 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07D 213/56 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/61 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 215/48 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 217/02 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 221/20 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 307/94 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/076427 Priority application(s): WO2008/076427

10 March 2011 Application Accepted

  Published as AU-B-2007334323

7 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007334331-Muscle derived cells for the treatment of gastro-esophageal pathologies and methods of making and using the same

2007334321-Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof